Feedback

AstraZeneca explains delays in vaccine supplies to EU

Source : 112 Ukraine

The problems with the extension of the vaccine production are observed in two factories – in the Netherlands and in Belgium
15:11, 27 January 2021

AFP

AstraZeneca CEO Pascal Soriot supported the efforts of the company on vaccine production amid the tension with the EU states due to the delays in the vaccine supplies as BBC reported.

Soriot stated his team works ‘24/7 to fix the very many issues of production of the vaccine’.  

He stated that the production of the drug is two months behind the rates planned by the company. Moreover, the late decision of the EU to sign contracts has restricted time for the elimination of issues with supplies.

Related: Moderna starts clinical trials of new vaccine against Covid-19 mutations

According to him, the problems with the extension of the vaccine production are observed in two factories – in the Netherlands and in Belgium.

As we reported, due to vaccine supply delays, the European Union has stepped up pressure on the British-Swedish pharmaceutical company AstraZeneca. EU states are considering ­suing AstraZeneca for breach of contract.

At the same time, European Commission President Ursula von der Leyen at the World Economic Forum in Davos called on vaccine manufacturers that have signed contracts with the EU to fulfill their obligations. According to her, Europe has contributed billions of dollars to the development of drugs from SARS-CoV-2 "and now the companies must fulfill their obligations and supply vaccines." Von der Leyen also announced that Brussels intends to create a mechanism to control the export of vaccines outside the EU.

Watch review of Year 2020 here:

 

 

Topics:
Система Orphus

If you find an error, highlight the desired text and press Ctrl + Enter, to tell about it

Comments
see more
latest news
editor's choice
video